HOME >> MEDICINE >> NEWS
NIDA grants will improve knowledge about inhalant abuse

In 2001, approximately 2 million youths between the ages of 12 and 17 reported that they had tried inhalants at some time in their lives. While inhalant abuse is one of the most prevalent drug problems among young people in the United States, relatively little research has been conducted on inhalant abuse.

To help remedy this lack of knowledge, the National Institute on Drug Abuse (NIDA) has awarded more than $2 million to fund seven grants focusing on issues related to inhalant abuse.

"Inhalants are widely abused by youngsters due to their easy accessibility through household products, as well as their low cost," says NIDA Acting Director Dr. Glen R. Hanson. "Furthermore, inhalant drug abuse poses definite dangers to the health of young children, including cognitive, neurological and physiological disorders, and the threat of sudden death, yet there is a severe paucity of research-based information about the problem." he adds.

The new research will focus on:

  • The epidemiology of inhalant abuse--the nature and extent of inhalant abuse, who is abusing them, and why, and the abuse of different types of inhalants in different age groups;

  • Individual risk and protective factors related to the initiation of inhalant use;

  • The effects of maternal inhalant abuse on the developing fetus; and

  • The health consequences of inhalant abuse.

Awards were made to the following investigators:

  • Ty Ridenuor, Washington University, Saint Louis, Missouri, Inhalant Abuse and Dependence;

  • Diana H. Fishbein, RTI, Research Triangle Park, North Carolina, Precursors, Insulators, and Consequences of Inhalant Use;

  • Diana J. Walker, University of Chicago, A Model of Inhalant Abuse Using Inhalant Responders;

  • Samuel J. Gately, Brookhaven National Laboratory, Upton, New York, Feto-Maternal Pharmacokinetics of Abused Inhalants;

  • Ruth W. Edwards, Colorado State University, Fort Collins,
    '"/>


Contact: Blair Gately
Bgately@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
5-Nov-2002


Page: 1 2

Related medicine news :

1. UNH launches 2nd spinout company with NIH grants
2. Disease testing for immigrants: Discrimination disguised as public health policy
3. US FDA grants full approval to DOXIL(R) following submission of phase III data
4. Four teams awarded inaugural translational cancer research grants
5. Immigrants, beware: Living in the United States is fattening
6. Prevalence of obesity among immigrants increases with longer residency in US
7. FDA grants accelerated approval of TYSABRI, formerly antegren, for the treatment of MS
8. Dana-Farber receives CDC grants to develop health promotion/prevention programs in the work place
9. Speech recognition experts at OGI School of Science & Engineering receive nearly $700,000 in grants
10. Should compulsory screening of immigrants be part of UK public health policy?
11. NIH grants support health disparities biomedical research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIDA grants will improve knowledge about inhalant abuse

(Date:5/19/2013)... The muscles in the human body are ... of the biggest and most significant nervous systems in ... system comprises of peripheral nerves that reside outside of ... that the limbs and hands, as well as other ... damaged due to trauma or physical injury, their functionality ...
(Date:5/19/2013)... Los Angeles, California (PRWEB) May 19, 2013 ... more damage than just losing sleep, or annoying your ... 9, 2013 report by CNY Central (“Snoring and Teeth ... a certain type of teeth grinding can be hard ... around 12 million Americans, and one of its symptoms ...
(Date:5/19/2013)... Christi, TX (PRWEB) May 19, 2013 ... security systems companies. Homeowners who are considering an ... and services of the nation's leading security system providers ... systems reviews the best DIY home security system ... Every year 6Webs.com reviews dozens of home security companies ...
(Date:5/19/2013)... 19, 2013 The report “Feed Additives ... & Forecasts up to 2017” published by MarketsandMarkets, defines ... analysis and forecasting of the global volume and revenue ... driving and restraining factors for the global market with ... challenges. The market is segmented and revenue is forecasted ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The Pradaxa ... Management Conference was recently convened for hundreds of ... litigation now underway in U.S. District Court, Southern District ... Court’s website on May 14th, the Conference addressed the ... also reported during the Conference that Defendants submitted a ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group has ... their competitive landscape map for the Chronic Kidney ... 90 international companies with drugs and devices currently ... and its sequelae. (Logo:  ... , hypertension - renal denervation , ...
(Date:5/17/2013)... Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) ... new, patent-pending technologies poised to redefine how consumers receive energy, ... a business update teleconference and webcast for shareholders and the ... 4:30 PM ET. Fuse Science, Inc. CEO, ... and will be joined by Rubin Hanan ...
(Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...
Breaking Medicine Technology:TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
Cached News: